BRFSS conducts annual state-based, random-digit-dialed telephone surveys of the noninstitutionalized U.S. civilian population aged >18 years, collecting data on health conditions and health risk behaviors, including binge drinking. In 2004, an optional survey module with additional questions on binge drinking was administered in 14 states. ¶ Binge drinking was defined as having consumed five or more alcoholic drinks on one or more occasions during the preceding 30 days. For this report, responses to questions regarding the prevalence, frequency, and intensity of binge drinking were analyzed, beginning with the question, "Considering all types of alcoholic beverages, how many times during the past 30 days did you have five or more drinks on an occasion?" Those who acknowledged at least one occasion were then asked, "During the most recent occasion when you had five or more alcoholic beverages, about how many beers, including malt liquor, did you drink? ...about how many glasses of wine, including wine coolers, hard lemonade, or hard cider, did you drink? ...about how many drinks of liquor, including cocktails, did you have?" After excluding persons with missing or incomplete information, data from 62,684 respondents in the 14 states were used The prevalence of binge drinking was calculated by dividing the total number of respondents who reported at least one binge drinking episode during the preceding 30 days by the total number of BRFSS respondents in the 14 states. Analysis by state was not performed because of multiple subgroups with fewer than 50 respondents. The frequency of binge drinking was calculated by averaging the number of episodes reported by all binge drinkers during the preceding 30 days. The intensity of binge drinking (i.e., number of drinks per binge episode) was calculated by averaging the number of drinks consumed by binge drinkers during their most recent episode. All data were weighted to produce population-based estimates according to age-, race-, and sex-specific state population counts and to the respondent's probability of selection. Data were adjusted to the standard age and sex distribution of 2004 BRFSS respondents to provide estimates for race/ethnicity, education level, and annual household income level. Statistical significance was determined by pairwise linear contrasts of the estimates (2) .
In 2004, the overall unadjusted prevalence of binge drinking among adults in the 14 states was 15.9% (Table 1) . Binge drinking prevalence among men (24.3%) was three times higher than among women (7.9%). Men who reported binge drinking also reported a significantly higher average number of binge drinking episodes during the preceding 30 days (4.6) than women (2.9) and a significantly higher number of drinks consumed during their most recent binge episode (8.3 versus 6.9) . Binge drinking prevalence decreased with advancing age, from 27.4% among respondents aged 18-24 years to 3.7% among respondents aged >65 years. In contrast, among binge drinkers, respondents aged >65 years reported the highest average number of binge drinking episodes during the preceding 30 days (6.8) . The number of drinks consumed during the most recent binge decreased with advancing age, from 9.8 among adults aged 18-24 years to 6.4 among those aged >65 years.
The age-and sex-adjusted prevalence of binge drinking among non-Hispanic whites (17.5%) was significantly higher than the prevalence for Hispanics (14.4%) and non-Hispanic blacks (10.9%) ( Table 2) . Overall, among binge drinkers, the frequency of binge drinking episodes and the number of drinks ** The response rate is the percentage of persons who completed interviews among all eligible persons, including those who were not successfully contacted. The cooperation rate is the percentage of persons who completed interviews among all eligible persons who were contacted.
for many other health risk factors (e.g., smoking and obesity), where prevalence tends to be higher among minorities and persons with lower education and income (4) . The findings in this report highlight the need for assessing the frequency and intensity of binge drinking among binge drinkers in addition to the prevalence of binge drinking in the general population. These additional measures are important because the risk for adverse outcomes (e.g., alcoholic liver disease or traffic fatalities) increases with the frequency of binge drinking and with the amount consumed per binge episode. Furthermore, reductions in the frequency and intensity of binge drinking generally might be expected to occur before reductions in the prevalence of binge drinking.
One plausible reason why binge drinking is more prevalent among whites and persons at higher income levels is that, unlike smoking, binge drinking has not been widely recognized as a health risk, subjected to intense prevention efforts, and socially stigmatized (5) . The differences in binge drinking among population segments also likely reflects cultural factors and differences in state and local laws (6) that affect the price, availability, and marketing of alcoholic beverages. Finally, the increase in prevalence of binge drinking with increasing income levels likely reflects the fact that persons with higher household incomes have more disposable income available to spend on alcohol.
The findings in this report are subject to at least three limitations. First, the 14 states that administered the optional binge drinking module are not necessarily representative of all 50 states; therefore, the results cannot be generalized to the entire U.S. population. Second, BRFSS data are self-reported; alcohol consumption generally, and excessive drinking in particular, are underreported in surveys because of recall bias, social desirability response bias, and nonresponse bias (7) . Finally, in 2005, BRFSS changed the definition of binge drinking for women from five or more drinks per occasion to four or more drinks per occasion; the prevalence of binge drinking among women would have been higher using the new definition (8) . These findings support the need to implement effective population-based strategies (e.g., increasing alcohol excise taxes, limiting the number of retail outlets where alcohol is sold in a particular geographic area, and maintaining and enforcing age 21 years as the minimum age for legal drinking) (9, 10) to prevent binge drinking. In addition, the frequency and intensity of binge drinking should be routinely monitored to guide the development and evaluation of culturally appropriate binge drinking prevention and intervention strategies for groups at greater risk. (2) . Based on GYTS results, 7.4% of students aged 13-15 years reported having ever smoked cigarettes, 12.9% had ever smoked shisha, 3.2% currently smoked cigarettes, and 6.3% currently smoked shisha. Among never smokers aged 13-15 years, 13.0% reported they were likely to initiate cigarette smoking in the next year. Future declines in adolescent tobacco use in Iraq (and Baghdad) could be enhanced by expanding existing tobacco control programs to include prevention and cessation of the use of cigarettes and shisha, implementing measures that discourage adolescents who have never smoked from initiating tobacco use, expanding legislation to ban exposure to secondhand smoke in all indoor workplaces, and enacting legislation banning pro-tobacco advertising and sponsorship.
GYTS is a school-based survey developed by WHO, CDC, and the Canadian Public Health Association that collects data on students aged 13-15 years using a standardized methodology for constructing the sample frame, selecting schools and classes, and processing data (3). The Baghdad GYTS used a two-stage cluster sample design that produces representative samples of students in grades intermediate 1-3 and secondary 1, the grades attended by students aged 13-15 years. Schools were selected proportional to the number of students enrolled and the type of school. Classes within the selected schools were selected randomly. All students attending school in the selected classes on the day the survey was administered were eligible to participate.
During 2008, the Baghdad Administrative Division included 610 schools and 269,990 students in grades intermediate 1-3 and secondary 1. An estimated 90% of boys remain in school through intermediate grade 3 (S.M. Jasim, Iraq Ministry of Health, personal communication, 2008); however, girls are 40% less likely than boys to be enrolled in intermediate grades, and more than 33% of all students enrolled in intermediate 3 do not continue to secondary 1. A weighting factor was applied to each student record to account for the probability of selection at the school and class levels, adjust for nonresponse (by school, class, and student), and correct for population demographics (3). A total of 2,182 students aged 13-15 years completed the Baghdad 2008 GYTS from 25 selected schools. The school response rate was 100%, the class response rate was 100%, the student response rate was 94.0%, and the overall response rate was 94.0%.* A weighted average of GYTS data from individual surveys conducted in 21 countries and two geographic regions of the Eastern Mediterranean Region (EMR) of WHO was used for comparison. Each GYTS in the 23 EMR sites followed similar sample designs, data collection, and data processing procedures as the Baghdad GYTS.
Overall, 7.4% of surveyed students had ever smoked cigarettes, and 12.9% had ever smoked shisha (Table 1) . Boys were 97% more likely to have ever smoked shisha than to have ever smoked cigarettes (14.6% versus 7.4%, respectively), whereas girls were 51% more likely to have ever smoked shisha. Current use of shisha was twice that of cigarette smoking for boys (6.7% versus 3.3%) and girls (5.0% versus 2.7%). Overall, 13.0% of never smokers indicated they might initiate cigarette smoking in the next year. For boys and girls, potential initiation of cigarette smoking among never smokers was four times more prevalent than current cigarette smoking.
Among surveyed students, 29.2% reported being exposed to smoke in public places during the week preceding the survey, 39.3% reported that their parents smoked cigarettes, 13.1% reported that their parents smoked shisha, and 72.6% were in favor of banning smoking in public places (Table 2) . In response to questions regarding advertising, 59.6% of the students reported having seen any anti-cigarette media message during the preceding month; 67.9% had seen pro-cigarette advertising on billboards, 67.6% had seen pro-cigarette advertising at point of sale locations, and 59.8% had seen pro-cigarette advertising in newspapers or magazines. Overall, 13.2% of students reported that they owned an object with a cigarette brand logo on it, and 7.3% reported that they had been offered free cigarettes by a cigarette company representative. With regard to school curricula, 41.8% of students reported having been taught in school during the preceding year about the dangers of smoking. (5, 6) . In the 21st century, smoking shisha appears to be a new trend in tobacco use and has recently become a preferred form of tobacco smoking for young persons, specifically women, in the Arabian Peninsula (7). For Arab women, shisha smoking carries less of a cultural stigma than does cigarette smoking (5, 6) . This is a concern because the harmful health effects of shisha can exceed those of cigarette smoking (2) . Some reports indicate that the concentration of nicotine is higher from shisha smoking than from cigarette smoking (5, 6) . Levels of arsenic, chromium, and lead also are higher in shisha smoking compared to single cigarette use. Additionally, because shisha sessions typically last 45-60 minutes, shisha smokers inhale higher concentrations of these toxic substances (5, 6) . A second concern is that the current cigarette smoking rate for girls (2.7%) is twice that for adult female cigarette smokers in Iraq (8) . In addition, the likely initiation of cigarette smoking by girls who have never smoked cigarettes (11.8%) is significantly higher than the current cigarette smoking rate for girls (2.7%). These findings might indicate that girls' cigarette use is increasing, which, if the trend continues, will lead to an increase in the burden of disease caused by tobacco use in Iraq. A very different pattern is found for boys aged 13-15 years in the Baghdad GYTS. The prevalence of cigarette smoking for boys (3.3%) is much lower than for adult males (25.2%) in Iraq (8) , but the likely initiation of smoking by boys (13.7%) is approximately half the adult smoking rate. This pattern was found throughout the EMR and suggests the smoking behavior of males dramatically increases at some point beyond age 15 years (3).
Overall, current cigarette smoking in Baghdad (3.2%) is similar to that of the 21 WHO member states of the EMR (4.9%). Current smoking among boys in Baghdad (3.3%) is lower than the rate (7.3%) for the region, but the rate for girls is similar (2.7% and 2.0%, respectively). Data on shisha smoking by adolescents in the EMR are not available.
The findings in this report are subject to at least four limitations. First, because the sample surveyed was limited to youths attending school, it is not representative of all youths aged 13-15 years. Second, the findings apply only to youths who were in school on the day the survey was administered and who completed the survey. However, student response was high (94.0%), suggesting that bias attributed to absence or nonresponse was minimal. Third, data are based on self-reports of students, who might have underreported or overreported their tobacco use or that of their parents. The extent of this bias cannot be determined; however, responses to tobaccorelated questions in surveys similar to GYTS in the United States have shown good test-retest reliability (9) . Finally, the Baghdad GYTS did not include detailed questions on shisha, including specific questions on advertising and media, knowledge and attitudes concerning the health effects of shisha use, the likelihood of never shisha users to initiate shisha use, and the desire to stop using shisha. Future surveys need to add questions on these topics to gain a better understanding of the use of shisha.
By ratifying the WHO FCTC, the MOH of Iraq has obligated the government to develop a comprehensive tobacco control program. WHO has identified six policy areas that countries should include in their tobacco control programs to maximize effect: 1) raising taxes on tobacco; 2) banning advertising promotion and sponsorship; 3) reducing exposure to secondhand smoke; 4) establishing tobacco cessation programs; 5) informing the public regarding the dangers of tobacco; and 6) establishing surveillance programs aimed at monitoring tobacco use and policies (8) . During 2008, the MOH expanded tobacco control effort in Iraq and adopted some of the tenants of these policies by developing several tobacco control strategies in addition to conducting the GYTS. The MOH will need to further expand its tobacco control efforts to meet the goals WHO has established in each of the 
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six policy areas. Future surveys can be used to monitor and evaluate the programs implemented to meet those goals and obligations.
Progress Toward Interruption of Wild Poliovirus TransmissionWorldwide, 2008
Since 1988, when the Global Polio Eradication Initiative was established, the incidence of polio has decreased from an estimated 350,000 cases annually to 1,655 reported in 2008.* Cases of wild poliovirus (WPV) type 2 were last reported in October 1999, and indigenous WPV types 1 and 3 (WPV1 and WPV3) have been eliminated from all but four countries worldwide (Afghanistan, India, Nigeria, and Pakistan). This report updates previous reports (1,2) In Afghanistan and Pakistan, problems in accessing children in conflict-affected areas increased, and an upsurge in WPV1 and WPV3 cases occurred, including an outbreak of WPV1 in Punjab Province, Pakistan. In Africa, during 2008, sustained WPV transmission for >12 months after importation continued in Angola, Chad, the Democratic Republic of the Congo (DRC), Niger, and southern Sudan. Increased political oversight and accountability and improved vaccination outreach to insecure areas are needed to achieve the eradication goal. 
Wild Poliovirus Incidence

Vaccine-Derived Polioviruses
Vaccine-derived polioviruses (VDPVs) were detected from AFP cases in 2008 in seven countries. † † Of these, type 2 circulating VDPVs (cVDPVs) were identified in northern Nigeria, where transmission has continued since 2006 (148 cases to date) (5,6), and in DRC and Ethiopia, where new type 2 cVDPV outbreaks in 2008 were detected (two separate outbreaks of two and 11 cases in DRC and an outbreak of two cases in Ethiopia, to date).
Routine Vaccination
Global vaccination coverage of infants with 3 routine doses of trivalent OPV (OPV3) by age 12 months was estimated at 82% in 2007, the most recent year for which data are available. § § OPV3 coverage estimates for 2007 in the World Health Organization (WHO) regions were 70% in the South-East Asian Region, 73% in the African Region, 87% in the Eastern Mediterranean Region, and >92% in the American, European, and Western Pacific regions. National OPV3 coverage for 2007 ¶ ¶ was 83% in both Afghanistan and Pakistan, 62% in India, and 61% in Nigeria. However, routine OPV3 coverage <40% continues to be reported from northern Nigerian states, the Indian states of Bihar and Uttar Pradesh, and parts of Afghanistan and Pakistan.
Supplementary Immunization Activities
In 2008, a total of 241*** SIAs were conducted in 36 countries (57 national immunization days, 118 subnational immunization days, and 53 mop-up rounds), using a total of 2.46 billion doses of OPV, which were delivered to approximately 
Acute Flaccid Paralysis Surveillance
Acute flaccid paralysis (AFP) surveillance is fundamental to monitoring progress toward polio eradication. The AFP surveillance system tracks any case of AFP in a child aged <15 years or any case of paralytic illness in a person of any age when polio is suspected. The quality of surveillance for acute flaccid paralysis (AFP) is monitored by performance indicators. ¶ ¶ ¶ In 2008, each WHO region maintained the overall sensitivity of AFP surveillance at certification-standard levels (Table) . Since 2005, an operational target for all countries reporting WPV and for neighboring countries (considered at high risk for WPV importation) has been to achieve a nonpolio AFP rate of at least two cases per 100,000 children aged <15 years. In 2008, all four polio-endemic countries and the 15 previously polio-free countries with WPV importation reached this target rate nationally, although subnational surveillance quality varied substantially. Editorial Note: The Global Polio Eradication Initiative faced a number of challenges and impediments to progress in 2008, both in the four polio-endemic countries and in previously polio-free countries that had transmission resulting from WPV importations. At the end of 2008, two independent advisory bodies to WHO**** reviewed the progress of the eradication initiative and concluded that the remaining technical and operational challenges could be overcome in each of the polio-endemic countries (7, 8) . The advisory bodies concluded that the ultimate success of global polio eradication depended on 1) ensuring the political commitment of all polio-affected countries to attain the highest possible coverage during SIAs and 2) enhancing routine vaccination and surveillance.
Despite these challenges, specific signs of progress during 2008 were noted by the advisory committee. These included the success in interrupting indigenous transmission of WPV1 in western Uttar Pradesh, India, for 12 months and innovative management approaches to SIA implementation in parts of Nigeria, Pakistan, and Afghanistan, which demonstrated that operational challenges can be overcome with sufficient commitment by national and subnational authorities.
In India, low OPV effectiveness in the highest-risk communities (believed to be caused by a combination of high incidence of diarrheal diseases, malnutrition, and the high force of WPV infection attributed to crowding) has been identified as the key challenge to interrupting WPV transmission (9, 10) . Responses being explored include the use of inactivated poliovirus vaccine as a supplement to mOPV, development of a bivalent OPV containing both type 1 and type 3, other novel uses of OPV, and zinc supplementation.
In all other countries with ongoing WPV transmission, serious limitations in accessing and vaccinating children remain the major impediments to polio eradication. The type 2 cVDPV outbreaks in Nigeria, DRC, and Ethiopia reveal striking lapses in routine and SIA vaccination in parts of those countries because cVDPVs are biologically similar to WPVs in terms of infectivity and pathogenicity. In Nigeria, the key to success will be to scale-up throughout the country the communication, social mobilization, and operational improvements that were achieved in some areas of northern Nigeria. In Pakistan, SIA coverage gaps must be better addressed, not only in securitycompromised areas but in secure areas experiencing ongoing operational challenges. In Afghanistan, the challenge is making progress in the insecure areas. Prolonged transmission after WPV importation into affected countries will require continuing efforts to overcome the long-standing operational impediments limiting routine and SIA vaccination of children. These impediments will require improved engagement of health and political authorities in those countries, the exploration and implementation of other technical and operational innovations, and the continued coordinated effort of partners. † † † Most children received OPV doses during more than one SIA round. § § § WPV cases in Angola, Benin, Burkina Faso, Central African Republic, Chad, Cote d'Ivoire, DRC, Ethiopia, Ghana, Mali, Nepal, Niger, Sudan, and Togo; in Egypt, response SIAs were conducted after isolation of WPV from sewage. WPV1 was detected on two occasions in sewage in Egypt in 2008, representing two separate importation events, genetically linked to poliovirus originating in Sudan and India, respectively. ¶ ¶ ¶ Performance indicators are 1) the rate of AFP cases not caused by WPV (the nonpolio AFP rate), with a target for polio-free certification of at least one case per 100,000 children aged <15 years, and 2) the proportion of AFP cases with adequate stool specimens, with a target for certification of >80%. Adequate specimens are two stool specimens, collected at least 24 hours apart, within 14 days of onset of paralysis, and shipped on ice or frozen ice packs to a WHO-accredited laboratory, arriving at the laboratory in good condition. **** The Advisory Committee on Poliomyelitis Eradication and the Strategic Advisory Group of Experts on Immunization.
Use of Northern Hemisphere Influenza Vaccines by Travelers to the Southern Hemisphere
The influenza season in temperate climates extends from October through March in the northern hemisphere and from April through September in the southern hemisphere (1-3). Recent studies indicate that influenza viruses can circulate throughout the year in the tropics and that influenza is the most frequently acquired vaccine-preventable disease among those traveling to tropical and subtropical countries (2-5). Influenza outbreaks have been reported among persons who travel from the northern hemisphere to the southern hemisphere and among persons from the northern hemisphere on group tours (4-7). To reduce the risk for influenza during travel, the Advisory Committee on Immunization Practices (ACIP) recommends that persons from the northern hemisphere who are recommended for annual vaccination or who want to avoid influenza illness but have not yet received the 2008-09 influenza vaccine should consider being vaccinated 1) before travel to the southern hemisphere during influenza season, 2) before travel to the tropics at any time of year, or 3) when traveling as part of a tour group that includes persons from areas where influenza circulates during April-September (e.g., the southern hemisphere) (8) . Vaccine formulations for each hemisphere are updated yearly but might differ according to virus surveillance information from each hemisphere.
Vaccines prepared for use in the northern hemisphere typically are administered to U.S. travelers to the southern hemisphere, even when the vaccine formulation is less than optimal, because influenza vaccines prepared for use in the southern hemisphere are not widely available in the United States. However, this year the influenza virus strains represented in the 2008-09 northern hemisphere influenza vaccine currently available in the United States are identical to the strains represented in influenza vaccines intended for use in 2009 in the southern hemisphere (8, 9) .
Health-care providers should ask patients about upcoming travel plans, inform them regarding the risk for influenza during travel, and be aware that vaccination of travelers with the currently available northern hemisphere influenza vaccine will provide the most recently updated vaccine formulation for the southern hemisphere.
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